SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024670
Filing Date
2020-05-12
Accepted
2020-05-12 16:16:43
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crtx-10q_20200331.htm 10-Q 1748771
2 EX-31.1 crtx-ex311_7.htm EX-31.1 16102
3 EX-31.2 crtx-ex312_6.htm EX-31.2 16181
4 EX-32.1 crtx-ex321_8.htm EX-32.1 10634
5 EX-32.2 crtx-ex322_9.htm EX-32.2 10639
  Complete submission text file 0001564590-20-024670.txt   6784733

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT crtx-20200331.xml EX-101.INS 1673126
7 XBRL TAXONOMY EXTENSION SCHEMA crtx-20200331.xsd EX-101.SCH 41344
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crtx-20200331_cal.xml EX-101.CAL 43805
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crtx-20200331_def.xml EX-101.DEF 134042
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20200331_lab.xml EX-101.LAB 336768
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20200331_pre.xml EX-101.PRE 261310
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38890 | Film No.: 20869323
SIC: 2836 Biological Products, (No Diagnostic Substances)